Atrion Corp (ATRI)
418.93
-6.86
(-1.61%)
USD |
NASDAQ |
May 02, 15:53
Atrion Cash from Financing (Quarterly): -8.371M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.371M |
| September 30, 2023 | -3.224M |
| June 30, 2023 | -1.021M |
| March 31, 2023 | -4.419M |
| December 31, 2022 | -15.15M |
| September 30, 2022 | -9.106M |
| June 30, 2022 | -9.834M |
| March 31, 2022 | -6.947M |
| December 31, 2021 | -3.511M |
| September 30, 2021 | -10.01M |
| June 30, 2021 | -13.67M |
| March 31, 2021 | -3.784M |
| December 31, 2020 | -4.987M |
| September 30, 2020 | -3.201M |
| June 30, 2020 | -10.68M |
| March 31, 2020 | -12.11M |
| December 31, 2019 | -2.875M |
| September 30, 2019 | -2.875M |
| June 30, 2019 | -3.083M |
| March 31, 2019 | -2.501M |
| December 31, 2018 | -2.501M |
| September 30, 2018 | -2.501M |
| June 30, 2018 | -2.314M |
| March 31, 2018 | -2.222M |
| December 31, 2017 | -2.223M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.222M |
| June 30, 2017 | -6.404M |
| March 31, 2017 | -5.204M |
| December 31, 2016 | -1.915M |
| September 30, 2016 | -1.916M |
| June 30, 2016 | -2.754M |
| March 31, 2016 | -2.914M |
| December 31, 2015 | -1.635M |
| September 30, 2015 | -7.271M |
| June 30, 2015 | -9.471M |
| March 31, 2015 | -18.39M |
| December 31, 2014 | -12.94M |
| September 30, 2014 | -1.922M |
| June 30, 2014 | -8.403M |
| March 31, 2014 | -5.932M |
| December 31, 2013 | -6.381M |
| September 30, 2013 | -2.458M |
| June 30, 2013 | -3.025M |
| March 31, 2013 | -2.138M |
| December 31, 2012 | -20.95M |
| September 30, 2012 | -1.128M |
| June 30, 2012 | -4.577M |
| March 31, 2012 | -2.138M |
| December 31, 2011 | -0.988M |
| September 30, 2011 | -2.522M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-15.15M
Minimum
Dec 2022
-1.021M
Maximum
Jun 2023
-6.783M
Average
-4.987M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 0.352M |
| Retractable Technologies Inc | -0.1364M |
| Xtant Medical Holdings Inc | 0.325M |
| Asensus Surgical Inc | 0.172M |
| Catheter Precision Inc | -0.107M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 10.86M |
| Cash from Investing (Quarterly) | 0.42M |
| Free Cash Flow | -2.313M |
| Free Cash Flow Per Share (Quarterly) | 4.711 |
| Free Cash Flow to Equity (Quarterly) | 12.80M |
| Free Cash Flow to Firm (Quarterly) | 8.296M |
| Free Cash Flow Yield | -0.31% |